Sarath Lal Mannumbeth Renjithlal
Sarath Lal Mannumbeth Renjithlal publishes mostly in Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Emergency Medicine, on topics such as Atrial Fibrillation Management and Outcomes, Heart Failure Treatment and Management and Mechanical Circulatory Support Devices.
- World rank
- #5,154,218 of 7,710,434 ranked researchers
- Rank in United States
- #1,326,222 of 1,627,098
- Works
- 25
- Citations
- 40
- Citations per work
- 1.6
What does Sarath Lal Mannumbeth Renjithlal research?
Sarath Lal Mannumbeth Renjithlal's work is mostly in Medicine (59%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1559.1%
- Medicine1559.1%
- Everything else1040.9%
- 1Cardiology and Cardiovascular Medicine29% of their works
- 2Pulmonary and Respiratory Medicine11% of their works
- 3Emergency Medicine5% of their works
- 4Epidemiology5% of their works
- 5Oncology5% of their works
- 6Surgery4% of their works
Research topics
- Atrial Fibrillation Management and Outcomes
- Heart Failure Treatment and Management
- Mechanical Circulatory Support Devices
- Cardiovascular Health and Risk Factors
- Cardiac Arrest and Resuscitation
- Global Cancer Incidence and Screening
- Bone health and osteoporosis research
- Cardiovascular and Diving-Related Complications
Which keywords describe Sarath Lal Mannumbeth Renjithlal's research?
The keywords of their largest research topics: Guidelines, Epidemiology, Heart Failure, Risk Factors, Anticoagulant Therapy, Atrial Fibrillation, Diagnosis and Treatment.
- Resuscitation
- Mortality Rates
- Ideal Cardiovascular Health
- Extracorporeal Membrane Oxygenation
- Cardiovascular Health
- Cancer Incidence
- Treatment
- Atrial Fibrillation
- Risk Factors
- Epidemiology
- Guidelines
- Heart Failure
- Anticoagulant Therapy
- Diagnosis
- Bone Mineral Density
- Cardiac Arrest
- Cryptogenic Stroke
- Fractures
- Left Ventricular Assist Device
- Patent Foramen Ovale
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Guidelines62 topics
- Epidemiology52 topics
- Heart Failure52 topics
- Risk Factors42 topics
- Anticoagulant Therapy31 topic
- Atrial Fibrillation31 topic
- Diagnosis31 topic
- Treatment31 topic
- Bone Mineral Density21 topic
- Cancer Incidence21 topic
- Cardiac Arrest21 topic
- Cardiovascular Health21 topic
- Cryptogenic Stroke21 topic
- Extracorporeal Membrane Oxygenation21 topic
- Fractures21 topic
- Ideal Cardiovascular Health21 topic
- Left Ventricular Assist Device21 topic
- Mortality Rates21 topic
- Patent Foramen Ovale21 topic
- Resuscitation21 topic
Where does Sarath Lal Mannumbeth Renjithlal work?
Sarath Lal Mannumbeth Renjithlal's main affiliation in the publication record is Unity Health System, United States.
How many publications and citations does Sarath Lal Mannumbeth Renjithlal have?
OpenAlex counts 25 works and 40 citations for Sarath Lal Mannumbeth Renjithlal, an h-index of 3, ranking #5,154,218 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Sarath Lal Mannumbeth Renjithlal. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.